Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ericsson

Showing results (81-90 of 122) with videos related to

Pageof 13
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1975
Bovine factor X1 (Stuart factor): amino-acid sequence of heavey chainK Titani, K Fujikawa, D L Enfield, et al.
Biochemistry|February 19, 1980
Amino acid sequence of the light chain of bovine factor X1 (Stuart factor)D L Enfield, L H Ericsson, K Fujikawa, et al.
Biochemistry|December 26, 1978
Amino acid sequence of two cyanogen bromide fragments of glycogen phosphorylaseJ Hermann, K Titani, L H Ericsson, et al.
European Journal of Clinical Pharmacology|April 17, 1999
Pharmacokinetics and pharmacodynamics of clevidipine in healthy volunteers after intravenous infusionH Ericsson, C Fakt, L Höglund, et al.
British Journal of Clinical Pharmacology|May 21, 1999
Clinical and pharmacokinetic results with a new ultrashort-acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteersH Ericsson, C Fakt, A Jolin-Mellgård, et al.
Archives of Biochemistry and Biophysics|January 30, 1977
Human thrombin: partial primary structureA R Thompson, D L Enfield, L H Ericsson, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1974
A comparison of bovine prothrombin, factor IX (Christmas factor), and factor X (Stuart factor)K Fujikawa, M H Coan, D L Enfield, et al.
Diabetes, Obesity & Metabolism|July 11, 2012
Safety, pharmacokinetics and pharmacodynamics of multiple-ascending doses of the novel glucokinase activator AZD1656 in patients with type 2 diabetes mellitusL A Morrow, M Leonsson-Zachrisson, H Ericsson, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1975
Evidence of homologous relationship between thermolysin and neutral protease A of Bacillus subtilisP L Levy, M K Pangburn, Y Burstein, et al.
Applied and Environmental Microbiology|May 1, 1999
Division of Listeria monocytogenes serovar 1/2a strains into two groups by PCR and restriction enzyme analysisH Unnerstad, I Nilsson, H Ericsson, et al.
Pageof 13

Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1975
Bovine factor X1 (Stuart factor): amino-acid sequence of heavey chainK Titani, K Fujikawa, D L Enfield, et al.
Biochemistry|February 19, 1980
Amino acid sequence of the light chain of bovine factor X1 (Stuart factor)D L Enfield, L H Ericsson, K Fujikawa, et al.
Biochemistry|December 26, 1978
Amino acid sequence of two cyanogen bromide fragments of glycogen phosphorylaseJ Hermann, K Titani, L H Ericsson, et al.
European Journal of Clinical Pharmacology|April 17, 1999
Pharmacokinetics and pharmacodynamics of clevidipine in healthy volunteers after intravenous infusionH Ericsson, C Fakt, L Höglund, et al.
British Journal of Clinical Pharmacology|May 21, 1999
Clinical and pharmacokinetic results with a new ultrashort-acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteersH Ericsson, C Fakt, A Jolin-Mellgård, et al.
Archives of Biochemistry and Biophysics|January 30, 1977
Human thrombin: partial primary structureA R Thompson, D L Enfield, L H Ericsson, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1974
A comparison of bovine prothrombin, factor IX (Christmas factor), and factor X (Stuart factor)K Fujikawa, M H Coan, D L Enfield, et al.
Diabetes, Obesity & Metabolism|July 11, 2012
Safety, pharmacokinetics and pharmacodynamics of multiple-ascending doses of the novel glucokinase activator AZD1656 in patients with type 2 diabetes mellitusL A Morrow, M Leonsson-Zachrisson, H Ericsson, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1975
Evidence of homologous relationship between thermolysin and neutral protease A of Bacillus subtilisP L Levy, M K Pangburn, Y Burstein, et al.
Applied and Environmental Microbiology|May 1, 1999
Division of Listeria monocytogenes serovar 1/2a strains into two groups by PCR and restriction enzyme analysisH Unnerstad, I Nilsson, H Ericsson, et al.
Pageof 13